OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C Kurs - 1 Jahr
Baader Bank Düsseldorf Lang & Schwarz München Stuttgart Tradegate XETRA Quotrix| Emittent | OSSIAM |
| Auflagedatum | 10.11.2017 |
| Kategorie | Aktien |
| Fondswährung | EUR |
| Benchmark | |
| Ausschüttungsart | Thesaurierend |
| Total Expense Ratio (TER) | 0,17 % |
| Fondsgröße | 238.533.216,45 |
| Replikationsart | Physisch vollständig |
| Morningstar Rating | - |
Anlageziel OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR
So investiert der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR: The investment objective of the Fund is to replicate, before the Fund's fees and expenses, the performance of the Bloomberg PAB Europe DM ex Eurozone Large & Mid Cap Net Return Index (the “Index”, ticker: EUXPABNL) closing level. The Fund is a financial product that pursuant to Article 9(3) of Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability-related disclosures in the financial services sector (the “SFDR”) has the objective of reducing carbon emissions in view of achieving the long-term global warming objectives of the Paris Agreement through the replication of the Index. The Index is a Bloomberg Global Equity Paris-Aligned Index expressed in EUR, calculated and published by Bloomberg (the "Index Provider"). The anticipated level of tracking error in normal conditions is 1.00% over a one-year period.
Der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A2DVG2
| 3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2026 | |
|---|---|---|---|---|---|---|
| Performance | +11,50 % | +12,60 % | +10,81 % | +36,61 % | +67,33 % | +6,50 % |
| Outperformance ggü. Kategorie | +5,57 % | +5,38 % | -2,17 % | -0,93 % | +28,17 % | +1,68 % |
| Max Verlust | - | - | -2,58 % | -11,63 % | -25,57 % | - |
| Kurs | 173,02 € | 171,00 € | 174,38 € | 140,20 € | - | 192,90 € |
| Hoch | - | - | 187,72 € | - | - | - |
| Tief | - | - | 146,75 € | - | - | - |
Kennzahlen ISIN: LU1655103486
| Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
|---|---|---|---|---|
| Volatilität | 9,60 % | 9,50 % | 11,87 % | |
| Sharpe Ratio | +0,76 | +0,77 | +0,78 |
Zusammensetzung WKN: A2DVG2
Größte Positionen ISIN: LU1655103486
| Name | ISIN | Marktkapitalisierung | Gewichtung |
|---|---|---|---|
| AstraZeneca PLC | GB0009895292 | 272.107.694.663 € | 6,06 % |
| Novartis AG Registered Shares | CH0012005267 | 267.416.790.341 € | 5,30 % |
| Roche Holding AG | CH0012032048 | 322.707.932.397 € | 5,26 % |
| Nestle SA | CH0038863350 | 225.448.677.370 € | 4,41 % |
| HSBC Holdings PLC | GB0005405286 | 253.964.297.838 € | 3,71 % |
| Novo Nordisk AS Class B | DK0062498333 | 149.539.171.313 € | 3,16 % |
| Compagnie Financiere Richemont SA Class A | CH0210483332 | 105.183.135.438 € | 2,38 % |
| Unilever PLC | GB00BVZK7T90 | 136.233.887.453 € | 2,32 % |
| Rolls-Royce Holdings PLC | GB00B63H8491 | 128.502.389.226 € | 2,29 % |
| GSK PLC | GB00BN7SWP63 | 101.787.610.431 € | 2,23 % |
| Summe Top 10 | 37,14 % | ||
Weitere ETFs mit gleicher Benchmark
| ETF | TER | Größe | Perf 1J |
|---|---|---|---|
| OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR | 0,17 % | 238,53 Mio. € | +10,81 % |
| iShares MSCI USA CTB Enhanced ESG UCITS ETF EUR Hedged Acc | 0,10 % | 22,37 Mrd. € | +11,16 % |
| Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C | 0,10 % | 19,86 Mrd. € | +2,09 % |
| Amundi Index Solutions - Amundi EUR Corporate Bond ESG UCITS ETF 2 DR - EUR (C) | 0,14 % | 6,73 Mrd. € | +3,27 % |
| Vanguard FTSE Developed Europe UCITS ETF EUR Accumulation | 0,10 % | 6,59 Mrd. € | +16,49 % |